Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H.P. Acthar Gel for SLE Flares
NCT01769937Phase 4Completed
- Sponsor
- Fiechtner
- Start
- Oct 2012
- Primary completion
- Apr 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of repository corticotropin injection in systemic lupus erythematosus (SLE), sponsored by Fiechtner. Primary endpoint: Systemic Lupus Erythematosus Disease Activity Index 2000 at 14 days. Started Oct 2012; status: completed.
02
Drugs
repository corticotropin injection
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT01769937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01769937.